Vantage Biosciences Alternatives & Competitors

12 companies similar to Vantage Biosciences — Transforming diabetic eye disease with an oral treatment

Oculis

Oculis develops eye drops to treat ophthalmic diseases, improving patients' lives worldwid...

75 Post Ipo Equity $345.73M

Lausanne, Switzerland

Biotechnology Health Care +1

iCare

Establishing the next level of eye care.

474 Series Unknown

Vantaa, Finland

Biotechnology Health Care

Mestag Therapeutics

New therapies for inflammatory disease and cancer by targeting fibroblast immunology

42 Seed $11.00M

London, United Kingdom

Biotechnology Health Care +1

Sling Therapeutics

Focused on late-stage development of an oral small molecule for the treatment of thyroid e...

12 Series A $35.00M

Ann Arbor, United States

Biopharma Biotechnology +1

Track all Vantage Biosciences competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

CV6 Therapeutics, (NI) Ltd.

CV6 Therapeutics is dedicated to improving patients lives through the development of novel...

11 Series Unknown $8.00M

United Kingdom

Biotechnology Health Care +1

TRexBio

Decoding Human Tissue Biology to Create Revolutionary Therapeutics

62 Unknown $219.00M

South San Francisco, Unit...

Biopharma Biotechnology +1

Otivio AS

9 Undisclosed

Oslo, Norway

Biotechnology Health Care +1

Glaukos Corporation

Pioneering new treatments for chronic eye diseases

1033 Series F $121.00M

Aliso Viejo, United State...

Health Care Health and Wellness

Evommune

Developing innovative therapies that target key drivers of chronic inflammatory diseases.

69 Unknown $493.00M

Palo Alto, United States

Biotechnology Health Care +1

Sitryx

Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...

48 Series A $79.00M

Oxford, United Kingdom

Biotechnology Health Care +1

Takeda

Better Health, Brighter Future

37130 IPO $57.80M

Tokyo, Japan

Biotechnology Pharmaceutical

ROME Therapeutics

Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...

16 Acquired $199.00M

Boston, United States

Biotechnology Health Care +1

About Vantage Biosciences

Transforming diabetic eye disease with an oral treatment

Services

Drug development for inflammatory conditions, Oral treatments creation for diabetic retinopathy, Clinical trials execution

Target Customers

Patients with inflammatory diseases, Individuals with diabetic eye disease, Healthcare providers and clinics

Taxonomy

Clinical Stage, Neuroinflammatory Disease, Vision Loss Prevention, Diabetic Eye Disease, Ophthalmology, Pharmaceutical Development, Disease Modifying Therapy, Neurovascular Disorders, Drug Development, Diabetes-related Complications, Eye Health, Therapeutic Innovation, Microangiopathy

Business Model

B2B, B2D

Revenue Model

Licensing, Product Sales, Service Fee

Frequently Asked Questions

Top alternatives to Vantage Biosciences include Oculis, iCare, Mestag Therapeutics, Sling Therapeutics, CV6 Therapeutics, (NI) Ltd.. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Vantage Biosciences based on industry overlap, target customers, and business model.

Transforming diabetic eye disease with an oral treatment

Don't just read about them. Follow them.

BounceWatch watches Vantage Biosciences and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Vantage Biosciences Profile Oculis Alternatives iCare Alternatives Mestag Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Vantage Biosciences on 28 Jan 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.